关于重症病房重症疟疾管理的ISCCM立场声明
Ashit Hegde1, Akshay K Chhallani2, Bikram Gupta3
1Department of General Medicine and Critical Care, PD Hinduja National Hospital, Mumbai, Maharashtra, India.
这份立场论文为重症监护医生提供了关于在重症监护病房 (ICU) 管理严重疟疾的指导. 它解决了印度的挑战,疟疾是严重的公共卫生问题,影响了许多人的生活.
科学领域:
- 热带医学是一种热带医学.
- 关键护理医学 关键护理医学
- 传染病 传染病 传染病
背景情况:
- 疟疾是一个主要的全球健康问题,不成比例地影响印度等热带国家.
- 印度近95%的人口居住在疟疾流行地区,这对非洲以外的全球病例和死亡造成了重大贡献.
- 尽管有控制努力,严重疟疾的高死亡率仍然存在,由不断变化的流行病学和治疗挑战而复杂化.
研究的目的:
- 为重症监护医生提供管理严重疟疾病例的基本指导.
- 为了解决印度重症监护室 (ICU) 面临的具体挑战.
- 为在资源有限的环境中建立基于证据的严重疟疾管理建议.
主要方法:
- 这是一个立场论文,综合了当前的知识和专家意见.
- 它的重点是重症监护室 (ICU) 中严重疟疾的管理.
- 这篇论文考虑了印度独特的流行病学和临床背景.
主要成果:
- 由于疾病模式的变化和药物供应有限等因素,ICU中的严重疟疾管理具有挑战性.
- 发展中国家缺乏大规模随机试验,阻碍了指导方针的制定.
- 提供指导,以帮助医生在严重疟疾患者的关键决策.
结论:
- 在ICU中有效管理严重疟疾需要根据当地流行病学和资源的可用性量身定制的战略.
- 这份立场论文旨在弥合印度重症监护医生的基于证据的指导方针的差距.
- 遵守最新的管理协议对于改善严重疟疾患者的治疗结果至关重要.
更多相关视频
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
09:17Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
相关概念视频
Cystic Fibrosis: Management
Sinus disease and chronic...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
